Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
EV/Core EBITDA

    Back to All Ratios
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
   EV/Core EBITDA(x) 21.6624.4518.2430.428.26

What is the latest EV/Core EBITDA ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest EV/Core EBITDA ratio of SYNCOM FORMULATIONS (INDIA) is 21.66 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202521.66
Mar202424.45
Mar202318.24
Mar202230.42
Mar20178.26

How is EV/Core EBITDA of SYNCOM FORMULATIONS (INDIA) Trending?

Years EV/Core EBITDA % Change
Mar2025 21.66
-11.41
Mar2024 24.45
34.05
Mar2023 18.24
-40.04
Mar2022 30.42
268.28
Mar2017 8.26 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare EV/Core EBITDA ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,468.3 Cr NA -6.4% -20.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,764.0 Cr 2% 6.1% 4.7% Stock Analytics
DIVIS LABORATORIES ₹170,489.0 Cr 0.1% -3.5% 8% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,442.0 Cr -0.3% 3.8% 15.5% Stock Analytics
CIPLA ₹123,088.0 Cr 1.1% -1.1% 2.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,162.0 Cr 2% 4.8% 4.8% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) NA

-6.4%

-20.8%

SENSEX

0.9%

0.8%

7.1%


You may also like the below Video Courses